Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment

Autor: Carmelo Rizzari, Maria Caterina Putti, Antonella Colombini, Sara Casagranda, Giulia Maria Ferrari, Cristina Papayannidis, Ilaria Iacobucci, Maria Chiara Abbenante, Chiara Sartor, Giovanni Martinelli

Publikováno v: Hematology Reports, Vol 6, Iss 3 (2014)

In the last two decades great improvements have been made in the treatment of childhood acute lymphoblastic leukemia, with 5-year overall survival rates currently approaching almost 90%. In comparison, results reported in adolescents and young adults

Externí odkaz: https://doaj.org/article/9edda3eb374544a39e37cc69bf592f1a

L’emocromo: così convenzionale, così richiesto, ma così sconosciuto

Autor: Ester De Luca, Orsola Montini, Paola Corti, Elena Varotto, Sofia Chiaraluce, Giulia Maria Ferrari, Martina Lattuada, Margherita Calia

Publikováno v: QUADERNI ACP. 28:31-36

Complete blood count (CBC) is one of the mostly performed diagnostic exam. It can give a variety of informations about a child’s health status. The article has the aim of guiding the pediatrician into reading the the different values of the CBC, in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bdba902ad52b3ee6a4abc8a947ec1cf8
https://doi.org/10.53141/qacp.2021.31-36

Legionellosi in Pediatria

Autor: Luisa Impagnatiello, Chiara Bersanini, Marco Spinelli, Giulia Maria Ferrari, Andrea Biondi, Carmelo Rizzari

Publikováno v: Medico e Bambino pagine elettroniche. 23:99-102

The article describes the clinical course of a 2-year-old Rumanian girl affected by acute lymphoblastic leukaemia who presented with a severe pneumonia during the initial chemotherapy phase. The main features of the infection caused by the bacterium

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2cf5bfdcdbc6a329f4fddfd237267114
https://doi.org/10.53126/mebxxiiimg099

Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient

Autor: Sergio Foresti, S Radaelli, Andrea Biondi, Giulia Maria Ferrari, L Ocello, Davide Ippolito, Paola Corti, Cristina Gervasini, Raffaele Badolato, Francesco Saettini, F Dell'Acqua

Publikováno v: Pediatric hematology and oncology. 39(1)

Rubinstein-Taybi syndrome (RSTS) is an autosomal dominant disorder, caused by variants in CREBBP or EP300. Affected individuals present with distinctive craniofacial features, broad thumbs and/or halluces, intellectual disability and immunodeficiency

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6262574cc7f85175f92e9685c9e4a7c7
https://pubmed.ncbi.nlm.nih.gov/34018455

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Autor: Virginie Gandemer, Kirsten Bleckmann, Giovanni Cazzaniga, Anders Castor, Martin Schrappe, Rob Pieters, Andrea Biondi, Maria Grazia Valsecchi, Giulia Maria Ferrari, Valentino Conter, Hélène Cavé, Maurizio Aricò, Hans O. Madsen, Jan Stary, Silja Röttgers, Veronica Leoni, Vincent H.J. van der Velden, Rolf Köhler, Udo zur Stadt, Jan Zuna, Paola De Lorenzo, Vaskar Saha, Gabriele Escherich, Jeremy Hancock, Julia Alten

Publikováno v: Haematologica
Cazzaniga, G, De Lorenzo, P, Alten, J, Röttgers, S, Hancock, J, Saha, V, Castor, A, Madsen, H O, Gandemer, V, Cavé, H, Leoni, V, Köhler, R, Ferrari, G M, Bleckmann, K, Pieters, R, van der Velden, V, Stary, J, Zuna, J, Escherich, G, Stadt, U Z, Aricò, M, Conter, V, Schrappe, M, Valsecchi, M G & Biondi, A 2018, ' Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies ', Haematologica, vol. 103, no. 1, pp. 107-115 . https://doi.org/10.3324/haematol.2017.176917
Haematologica, 103(1), 107-115. Ferrata Storti Foundation

The prognostic value of minimal residual disease (MRD) in Philadelphia-chromosome-positive (Ph+) childhood acute lymphoblastic leukemia (ALL) treated with tyrosine kinase inhibitors is not fully established. We detected MRD by real-time quantitative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb63ad90c3991b9b3c794d6e2870446
https://pure.eur.nl/en/publications/682165d6-bf16-4188-a748-876de7951c83